A phase 3, single-arm study of CG0070 in subjects with nonmuscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).

Authors

null

Edward M. Uchio

University of California, Irvine Medical Center, Orange, CA

Edward M. Uchio , Donald L. Lamm , Neal D. Shore , Ashish M. Kamat , Mark Tyson , Ben Tran , Paul Anderson , Paola Grandi , James M. Burke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04452591

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr TPS598)

DOI

10.1200/JCO.2022.40.6_suppl.TPS598

Abstract #

TPS598

Poster Bd #

N4

Abstract Disclosures